Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and Currentum in connection with the acquisitions of Gullikssons El, Elkalkyl och Elprojektering and Reglerab
Mandate

Vinge advises Axcel VI and Currentum in connection with the acquisitions of Gullikssons El, Elkalkyl och Elprojektering and Reglerab

September 13, 2022 Employment and Benefits M&A Banking and Finance Real Estate and Construction

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of J. Gullikssons El Aktiebolag, Elkalkyl och Elprojektering i Sverige AB and Reglerab AB.

The companies provide services in planning, installation and service in the electrical and construction sectors and are based in Stockholm and Mälardalen. Together, the companies have a turnover of approximately SEK 155 million and approximately 100 employees. Following the acquisitions, Currentum is expected to have a turnover of approximately SEK 3 billion and will engage just over 1,000 employees.

Vinge’s team consisted of partner Christina Kokko together with Carl Fredrik Wachtmeister, Linnea Petersson and Philip Moré (M&A), Isak Willborg (Construction), Sara Strandberg (Employment), Calle Tengwall Pagels (Financing), Frida Ställborn (Real Estate) and Anna Ekdahl Roos (project assistant).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025